SSGJ-705 Clinical Trials
3 recruitingDrug
Phase 22Phase 11
Showing 1–3 of 3 trials
Recruiting
Phase 2
SSGJ-705 Plus SSGJ-612 ± Chemotherapy in Advanced HER2-Expressing Solid Tumors
Locally Advanced Unresectable or Metastatic Solid Tumors
Shenyang Sunshine Pharmaceutical Co., LTD.150 enrolled1 locationNCT07646626
Recruiting
Phase 2
SSGJ-705 Monotherapy and Combination Therapy in Advanced HER2-Expressing Solid Tumors
Locally Advanced, Recurrent or Metastatic Malignancies
Shenyang Sunshine Pharmaceutical Co., LTD.340 enrolled1 locationNCT07022002
Recruiting
Phase 1
A Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of SSGJ-705 Monotherapy in Patients with Advanced Malignant Tumors
Locally Advanced, Recurrent or Metastatic Malignancies
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.180 enrolled1 locationNCT06390774